{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:14:05Z","timestamp":1761560045123},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10384-019-00673-8","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:22:02Z","timestamp":1558556522000},"page":"322-327","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series"],"prefix":"10.1007","volume":"63","author":[{"given":"Hee Jung","family":"Joh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Wook","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"673_CR1","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma, 4th edition, \n                    http:\/\/bjo.bmj.com\/content\/bjophthalmol\/101\/4\/1.full.pdf\n                    \n                  .","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.001"},{"key":"673_CR2","volume-title":"Preferred practice pattern guidelines. Primary open angle glaucoma","author":"American Academy of Ophthalmology Glaucoma Panel","year":"2010","unstructured":"American Academy of Ophthalmology Glaucoma Panel. Preferred practice pattern guidelines. Primary open angle glaucoma. San Francisco: American Academy of Ophthalmology; 2010."},{"key":"673_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2165\/00002512-200825090-00002","volume":"25","author":"CA Webers","year":"2008","unstructured":"Webers CA, Beckers HJ, Nuijts RM, Schouten JS. Pharmacological management of primary open-angle glaucoma: second-line options and beyond. Drugs Aging. 2008;25:729\u201359.","journal-title":"Drugs Aging"},{"key":"673_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/archopht.1994.01090170088028","volume":"112","author":"HA Quigley","year":"1994","unstructured":"Quigley HA, Enger C, Katz J, Sommer A, Scott R, Gilbert D. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644\u20139.","journal-title":"Arch Ophthalmol"},{"key":"673_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"EJ Higginbotham","year":"2002","unstructured":"Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, et al. The ocular hyperten-sion treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u201313.","journal-title":"Arch Ophthalmol"},{"key":"673_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10384-018-0599-0","volume":"62","author":"K Inoue","year":"2018","unstructured":"Inoue K, Ishida K, Tomita G. Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin\/timolol fixed combination therapy or adding ripasudil. Jpn J Ophthalmol. 2018;62:508\u201316.","journal-title":"Jpn J Ophthalmol"},{"key":"673_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10384-018-0635-0","volume":"63","author":"T Komizo","year":"2019","unstructured":"Komizo T, Ono T, Yagi A, Miyata K, Aihara M. Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma. Jpn J Ophthalmol. 2019;63:40\u20135.","journal-title":"Jpn J Ophthalmol"},{"issue":"Suppl 1","key":"673_CR8","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","volume":"53","author":"GF Schwartz","year":"2008","unstructured":"Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Opththalmol. 2008;53(Suppl 1):S57\u201368.","journal-title":"Surv Opththalmol"},{"key":"673_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2005.02.043","volume":"140","author":"HS Barnebey","year":"2005","unstructured":"Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, et al. The safety and efficacy of travoprost 0.004%\/timolol 0.5% fixed combination ophthalmic solution. Am J Ophthalmol. 2005;140:1\u20137.","journal-title":"Am J Ophthalmol"},{"key":"673_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/OPTH.S3840","volume":"2","author":"AJ Lee","year":"2008","unstructured":"Lee AJ, McCluskey P. Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure. Clin Ophthalmol. 2008;2:545\u201355.","journal-title":"Clin Ophthalmol"},{"key":"673_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10384-012-0186-8","volume":"56","author":"K Inoue","year":"2012","unstructured":"Inoue K, Shiokawa M, Sugahara M, Wakakura M, Soeda S, Tomita G. Three-month evaluation of dorzolamide hydrochloride\/timolol maleate fixed-combination eye drops versus the separate use of both drugs. Jpn J Ophthalmol. 2012;56:559\u201363.","journal-title":"Jpn J Ophthalmol"},{"key":"673_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ophtha.2008.12.054","volume":"116","author":"CC Tham","year":"2009","unstructured":"Tham CC, Kwong YY, Leung DY, Lam SW, Li FC, Chiu TY, et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology. 2009;116:725\u201331.","journal-title":"Ophthalmology"},{"key":"673_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","volume":"25","author":"A Behrens","year":"2006","unstructured":"Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900\u20137.","journal-title":"Cornea"},{"key":"673_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"The DEWS Definition and Classification Subcommittee","year":"2007","unstructured":"The DEWS Definition and Classification Subcommittee. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5:75\u201392.","journal-title":"Ocul Surf"},{"key":"673_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/jop.2013.0229","volume":"30","author":"G Holl\u00f3","year":"2014","unstructured":"Holl\u00f3 G, Hommer A, Ant\u00f3n L\u00f3pez A, Ropo A. Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%\/timolol 0.5% versus concomitant use of the ingredients. J Ocul Pharmacol Ther. 2014;30:468\u201375.","journal-title":"J Ocul Pharmacol Ther"},{"key":"673_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/OPTH.S150595","volume":"12","author":"K Inoue","year":"2018","unstructured":"Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, et al. Switching from concomitant therapy to tafluprost\/timolol fixed combination. Clin Ophthalmol. 2018;12:549\u201354.","journal-title":"Clin Ophthalmol"},{"key":"673_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/jop.2017.0075","volume":"34","author":"SW Jin","year":"2018","unstructured":"Jin SW, Lee SM. The efficacy and safety of the fixed combination of brinzolamide 1% and brimonidine 02% in normal tension glaucoma: an 18-month retrospective study. J Ocul Pharmacol Ther. 2018;34:274\u20139.","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-019-00673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-019-00673-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-019-00673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T23:39:00Z","timestamp":1589931540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-019-00673-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1007\/s10384-019-00673-8","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"13 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H. J. Joh, None; S. W. Jin, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}